Partially Sequential Random Batch Monitoring and Its Applications

来源 :上海交通大学 | 被引量 : 0次 | 上传用户:sqs292241644
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  We introduce a class of nonparametric two-sample tests based on a new partially sequential sampling scheme.
其他文献
Chinas local government debt financing grows rapidly since the global financial crisis in 2008,featuring surging exposure of local government debt risk.
Covariate measurement error has attracted extensive interest in survival analysis.In the past thirty years,a large number of inference methods have been developed to handle error-prone survival data.
Faced with new types of data,statisticians require models that can handle complex random objects.This motivates the development of regression models that feature random objects in a metric space as re
We consider the estimation of the optimal interval between doses for interventions such as malaria chemoprevention and vaccine booster doses that are applied intermittently in infectious disease contr
Interval-censored failure time data occur in many fields such as demography,economics,medical research and reliability and many inference procedures on them have been developed(Chen et al.,2012; Sun,2
The Affordable Care Act(ACA),which expanded health insurance coverage to millions of people in the United States,created interest in evaluating the effect of gaining Medicaid health insurance on patie
In this article,we propose a Bayesian stochastic approximation method to estimate the root of a regression function.The method features adaptive modelling and nonrecursive iteration.
Approximate Bayesian computing(ABC)is a likelihood-free method that has grown increasingly popular since early applications in population genetics.
Motivated by the need to produce small area estimates for the National Resources Inventory survey,we develop a spatial hierarchical Bayesian model based on a generalized Dirichlet distribution to cons
Background: Phase trials are designed to determine the safety,tolerability and recommended phase 2 dose of therapeutic agents for subsequent testing.